Invention Grant
- Patent Title: Heterocyclic methyl sulfone derivative
- Patent Title (中): 杂环甲基砜衍生物
-
Application No.: US10561838Application Date: 2004-06-29
-
Publication No.: US07932271B2Publication Date: 2011-04-26
- Inventor: Hideki Kubota , Takanori Yasukouchi , Satoru Miyauchi , Kayoko Motoki , Masanori Saito , Hitoshi Iimori
- Applicant: Hideki Kubota , Takanori Yasukouchi , Satoru Miyauchi , Kayoko Motoki , Masanori Saito , Hitoshi Iimori
- Applicant Address: JP Tokyo
- Assignee: Daiichi Pharmaceutical Co., Ltd.
- Current Assignee: Daiichi Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2003-187796 20030630; JP2004-099151 20040330
- International Application: PCT/JP2004/009132 WO 20040629
- International Announcement: WO2005/000798 WO 20050106
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D401/00 ; C07D213/72 ; C07D213/00

Abstract:
Provided is a compound capable of inhibiting production or secretion of β amyloid protein.A compound represented by the following formula (1): (wherein, R1 represents a heterocyclic group which may have a substituent, R2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R4 represents a hydrogen atom or a C1-6 alkyl group, and X represents —S—, —SO— or —SO2—); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.
Public/Granted literature
- US20060241302A1 Morpholine derivatives Public/Granted day:2006-10-26
Information query